Home
Mohn Cancer Research Laboratory

Tumour heterogeneity

Main content

Breast cancer (like most solid tumours) are heterogeneous. This means that every tumour consists of several subclones which are genetically different due to alterations arising during the evolution of the disease.

In collaboration with the Sanger Institute, we have performed multiple studies mapping the heterogeneity in early-stage (primary) breast tumours and the evolution of subclones, over time, towards a more advanced stage of the disease where the cancer has spread to other organs.

 

Key publications: 

 

Bilder fra labforsøk
Photo:
Laura Minsaas